Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12112074 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: ACTOS (Pioglitazone)

Indicates status has not been verified in more than two years